eGenesis
The Research Associate II will join the Analytical Development team to develop and qualify methods for assessing transgene expression and function in genetically modified porcine cells. The role involves extensive cell culture work, including isolation and maintenance of primary porcine cells, and characterization using flow cytometry, ELISA, and PCR assays. The candidate will independently plan, execute, and troubleshoot analytical assays while collaborating with QC and presenting findings.
Headquarters
Cambridge, Massachusetts, United States
Company Size
51-200 employees
Founded
2015
eGenesis is a biotechnology company developing gene-edited organ and cell therapies for transplantation, with a focus on xenotransplantation using engineered pig organs and tissues.
FDA greenlights trial of gene-edited pig kidneys as treatment for end-stage kidney disease
Sep 8, 2025
Scientists Grow More Hopeful About Ending a Global Organ Shortage
Nov 12, 2025
eGenesis Secures IND Clearance for EGEN-2784 in Kidney Transplant and Reports Significant Patient Progress
Sep 9, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for eGenesis.
14% above the average for this role
eGenesis to Present at 44th Annual J.P. Morgan Healthcare Conference
Jan 7, 2026
Senior Associate Scientist - Discovery Research, Regeneron Cell Medicines
Regeneron Pharmaceuticals
Specialist, QC Analytical
AstraZeneca
Senior Research Associate*
bighatbiosciences
Research Specialist A
University of Pennsylvania
Research Associate (Cell Biology & Immunology)
Discovery Life Sciences
Analytical Development Scientist
Artiva Biotherapeutics